torcetrapib has been researched along with Anesthesia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, TJ; Cox, BF; Gintant, GA; Kempf-Grote, AJ; King, AJ; Marsh, KC; Mittelstadt, SW; Nelson, RA; Polakowski, JS; Preusser, LC | 1 |
| Chen, RR; Chi, L; Dinallo, RM; Fryer, RM; Harrington, KE; Harrison, PC; Muthukumarana, A; Ng, KJ; Nodop Mazurek, SG; Reinhart, GA | 1 |
2 other study(ies) available for torcetrapib and Anesthesia
| Article | Year |
|---|---|
Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
Topics: Anesthesia; Animals; Blood Pressure; Cardiac Output; Cardiovascular System; Cholesterol Ester Transfer Proteins; Dogs; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Contraction; Pentobarbital; Quinolines; Telemetry; Vascular Resistance; Ventricular Function, Left | 2009 |
Strategic integration of in vivo cardiovascular models during lead optimization: predictive value of 4 models independent of species, route of administration, and influence of anesthesia.
Topics: Administration, Oral; Anesthesia; Animals; Anticholesteremic Agents; Blood Pressure; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Infusions, Intravenous; Male; Models, Animal; Quinolines; Rats; Rats, Sprague-Dawley; Species Specificity | 2012 |